Advances in current in vitro models on neurodegenerative diseases

Front Bioeng Biotechnol. 2023 Nov 6:11:1260397. doi: 10.3389/fbioe.2023.1260397. eCollection 2023.

Abstract

Many neurodegenerative diseases are identified but their causes and cure are far from being well-known. The problem resides in the complexity of the neural tissue and its location which hinders its easy evaluation. Although necessary in the drug discovery process, in vivo animal models need to be reduced and show relevant differences with the human tissues that guide scientists to inquire about other possible options which lead to in vitro models being explored. From organoids to organ-on-a-chips, 3D models are considered the cutting-edge technology in cell culture. Cell choice is a big parameter to take into consideration when planning an in vitro model and cells capable of mimicking both healthy and diseased tissue, such as induced pluripotent stem cells (iPSC), are recognized as good candidates. Hence, we present a critical review of the latest models used to study neurodegenerative disease, how these models have evolved introducing microfluidics platforms, 3D cell cultures, and the use of induced pluripotent cells to better mimic the neural tissue environment in pathological conditions.

Keywords: 3D in vitro models; bioprinting; iPSC cell culture; microfluidic device; neurodegenerative diseases.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Networking Biomedical Research Center (CIBER), in Spain. CIBER is an initiative funded by the VI National R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions, and the Instituto de Salud Carlos III (RD16/0006/0012), with the support of the European Regional Development Fund (ERDF). This work was funded by the C CERCA Program, and by the Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya (2017 SGR 1079), and the Spanish Ministry of Economy and Competitiveness (MINECO) through the project NEUR-ON-A-CHIP (RTI2018-097038-B-C21 and RTI2018-097038-B-C22). This study was developed in the context of AdvanceCat and Base3D with the support of ACCIÓ (Catalonia Trade and Investment; Generalitat de Catalunya) under the Catalonian ERDF operational program (European Regional Development Fund) 2014–2020. IP is a fellow of the European Union’s Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie Innovative Training Networks (ASCTN Training Network, grant agreement No. 813851).